Viking Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update

Go back to Viking Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update

Viking Therapeutics (VKTX) Reports In-Line Q2 EPS

July 28, 2021 4:34 PM EDT

Viking Therapeutics (NASDAQ: VKTX) reported Q2 EPS of ($0.20), in-line with the analyst estimate of ($0.20).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

... More